To Compare The Effect Of Pippalyadi Choorna And Fluconazole In Kaphaja Yonivyapad (Vulvovaginal Candidiasis)

An Open Label Randomized Standard Drug Controlled Interventional Clinical Study To Evaluate The Effect Of Pippalyadi Choorna In The Management Of Kaphaja Yonivyapad vis-à-vis Vulvovaginal Candidiasis - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/09/057592

Enrollment

Registered

2023-09-13

Start date

Unknown

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Married women

Exclusion criteria

Exclusion criteria: 1.Unmarried women 2.Known case of cervical neoplastic lesions, 3.Known case of diabetes mellitus 4.Pregnant and Lactating Women 5.Subjects on hormonal therapy 6.Subjects who had anti-fungal coverage within 1 month, oral and local corticosteroids for less than past 6 months.

Design outcomes

Primary

Measure	Time frame
Reduction in thick white discharge per vaginaTimepoint: Intervention period- 15days	—

Secondary

Measure	Time frame
Reduction in the symptoms like Itching per vagina, dysuriaTimepoint: follow up - 30th day	—

Countries

India

Contacts

Public ContactDr Tejaswini K R

Jagadguru Sri Shivarathreeshwara Medical College and hospital Mysuru

tejteju9@gmail.com8762409110

Outcome results